[Jerusalem, Israel] - A new international study conducted by the Israeli Phage Therapy Center (IPTC) led by Prof. Ran Nir-Paz at Hadassah Hebrew University Medical Center and Prof. Ronen Hazan of the Faculty of Dental Medicine at The Hebrew University of Jerusalem, using phage PASA16 on compassionate basis to treat tough Pseudomonas aeruginosa infections, has shown promising results with an 86.6% success rate. This research involving 16 patients with persistent infections represents the largest of its kind and brings encouraging findings.
https://www.miragenews.com/phage-pasa16-virus-cures-86-6-of-antibiotic-1062758/#miragenews
Sinun täytyy kirjautua sisään ennen kuin voit kommentoida.